These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38276679)

  • 21. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
    Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
    Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ongoing measles outbreaks in Romania, March 2023 to August 2023.
    Lazar M; Pascu C; Roșca M; Stănescu A
    Euro Surveill; 2023 Aug; 28(35):. PubMed ID: 37650907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress Toward Measles Elimination - European Region, 2009-2018.
    Zimmerman LA; Muscat M; Singh S; Ben Mamou M; Jankovic D; Datta S; Alexander JP; Goodson JL; O'Connor P
    MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):396-401. PubMed ID: 31048675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of a prolonged ebola outbreak on measles elimination activities in Guinea, Liberia and Sierra Leone, 2014-2015.
    Masresha BG; Luce R; Weldegebriel G; Katsande R; Gasasira A; Mihigo R
    Pan Afr Med J; 2020; 35(Suppl 1):8. PubMed ID: 32373259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States.
    Parker AA; Staggs W; Dayan GH; Ortega-Sánchez IR; Rota PA; Lowe L; Boardman P; Teclaw R; Graves C; LeBaron CW
    N Engl J Med; 2006 Aug; 355(5):447-55. PubMed ID: 16885548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measles outbreaks: they are preventable but keep progressing dangerously.
    Smiianov VA; Kurhanska VA; Smiianova OI
    Wiad Lek; 2019; 72(11 cz 1):2145-2148. PubMed ID: 31860862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitigating Vaccine Hesitancy and Building Trust to Prevent Future Measles Outbreaks in England.
    Thompson S; Meyer JC; Burnett RJ; Campbell SM
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress Toward Measles and Rubella Elimination - India, 2005-2021.
    Murugan R; VanderEnde K; Dhawan V; Haldar P; Chatterjee S; Sharma D; Dzeyie KA; Pattabhiramaiah SB; Khanal S; Sangal L; Bahl S; Tanwar SSS; Morales M; Kassem AM
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(50):1569-1575. PubMed ID: 36520657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran.
    Saffar H; Khalifeloo M; Saffar MJ; Abdollahi A; Parsaei MR; Ghorbani GR; Salarvand S; Aarabi M
    BMC Infect Dis; 2021 Mar; 21(1):305. PubMed ID: 33765968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measles outbreak response immunization during the COVID-19 pandemic: lessons from Borno State, Nigeria.
    Nomhwange T; Mohammed A; Jean Baptiste AE; Musa A; Yusuf A; Yusuf M; Wagai J; Shettima A; Meleh S; Banda R; Braka F; Luce R; Masresha B
    Pan Afr Med J; 2022; 41():104. PubMed ID: 35432705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Why are young adults affected? Estimating measles vaccination coverage in 20-34 year old germans in order to verify progress towards measles elimination.
    Schuster M; Stelzer T; Burckhardt F
    PLoS Curr; 2015 Feb; 7():. PubMed ID: 25789202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Public Health and Economic Consequences of Vaccine Hesitancy for Measles in the United States.
    Lo NC; Hotez PJ
    JAMA Pediatr; 2017 Sep; 171(9):887-892. PubMed ID: 28738137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measles in vulnerable populations: An outbreak in Roma settlements of Loire-Atlantique, France, 2019.
    Lefebvre M; Gross L; Ollivier R; Bailly S; Coste-Burel M; Coutherut J; Dina J
    J Med Virol; 2023 Dec; 95(12):e29321. PubMed ID: 38108193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invalid measles vaccine dose administration and vaccine effectiveness in Ethiopia.
    Desta T; Lemango E; Wayessa D; Wondowossen L; Kerie M; Masresha B
    Pan Afr Med J; 2021; 40():229. PubMed ID: 35145591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying immunity gaps for measles using Belgian serial serology data.
    Schenk J; Abrams S; Litzroth A; Cornelissen L; Grammens T; Theeten H; Hens N
    Vaccine; 2022 Jun; 40(26):3676-3683. PubMed ID: 35589453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress towards measles elimination in Singapore.
    Ho HJ; Low C; Ang LW; Cutter JL; Tay J; Chan KP; Ooi PL; Thoon KC; Goh KT
    Vaccine; 2014 Dec; 32(51):6927-6933. PubMed ID: 25444818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress toward measles elimination--European Region, 2005--2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(6):142-5. PubMed ID: 19229166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Onward transmission of measles virus among vaccinated cases in a large community outbreak in Auckland, New Zealand, 2019.
    Evans I; Jury S; Morrison A; Best E; King V; Reynolds E
    Vaccine; 2024 Oct; 42(23):126257. PubMed ID: 39191179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Avoiding missed opportunities for immunization in the Central African Republic: potential impact on vaccination coverage.
    Kahn JG; Mokdad AH; Deming MS; Roungou JB; Boby AM; Excler JL; Waldman RJ
    Bull World Health Organ; 1995; 73(1):47-55. PubMed ID: 7704925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measles Epidemics in Romania: Lessons for Public Health and Future Policy.
    Dascalu S
    Front Public Health; 2019; 7():98. PubMed ID: 31073518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.